These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30113067)

  • 1. Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps.
    Berry KN; Kober DL; Su A; Brett TJ
    Bioessays; 2018 Oct; 40(10):e1800086. PubMed ID: 30113067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein.
    Zadeh VR; Urata S; Sakaguchi M; Yasuda J
    J Gen Virol; 2020 Jun; 101(6):573-586. PubMed ID: 32375950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor.
    Swiecki M; Omattage NS; Brett TJ
    Mol Immunol; 2013 Jun; 54(2):132-9. PubMed ID: 23274150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetherin and its viral antagonists.
    Kuhl BD; Cheng V; Wainberg MA; Liang C
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):188-201. PubMed ID: 21222046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Tethering the Viral Particles: Immunomodulatory Functions of Tetherin (
    Tiwari R; de la Torre JC; McGavern DB; Nayak D
    DNA Cell Biol; 2019 Nov; 38(11):1170-1177. PubMed ID: 31502877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.
    Radoshitzky SR; Dong L; Chi X; Clester JC; Retterer C; Spurgers K; Kuhn JH; Sandwick S; Ruthel G; Kota K; Boltz D; Warren T; Kranzusch PJ; Whelan SP; Bavari S
    J Virol; 2010 Oct; 84(20):10569-80. PubMed ID: 20686043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?
    Andrew A; Strebel K
    J Interferon Cytokine Res; 2011 Jan; 31(1):137-44. PubMed ID: 21166593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.
    Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction.
    Le Tortorec A; Willey S; Neil SJ
    Viruses; 2011 May; 3(5):520-40. PubMed ID: 21994744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
    Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
    J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.
    Blanchet FP; Stalder R; Czubala M; Lehmann M; Rio L; Mangeat B; Piguet V
    Retrovirology; 2013 Jan; 10():6. PubMed ID: 23311681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.
    Mangeat B; Cavagliotti L; Lehmann M; Gers-Huber G; Kaur I; Thomas Y; Kaiser L; Piguet V
    J Biol Chem; 2012 Jun; 287(26):22015-29. PubMed ID: 22493439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.
    Dufrasne FE; Lombard C; Goubau P; Ruelle J
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27754450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BST-2 restricts IAV release and is countered by the viral M2 protein.
    Hu S; Yin L; Mei S; Li J; Xu F; Sun H; Liu X; Cen S; Liang C; Li A; Guo F
    Biochem J; 2017 Feb; 474(5):715-730. PubMed ID: 28087685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The great escape: viral strategies to counter BST-2/tetherin.
    Douglas JL; Gustin JK; Viswanathan K; Mansouri M; Moses AV; Früh K
    PLoS Pathog; 2010 May; 6(5):e1000913. PubMed ID: 20485522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Activity and Adaptive Evolution of Avian Tetherins.
    Krchlíková V; Fábryová H; Hron T; Young JM; Koslová A; Hejnar J; Strebel K; Elleder D
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
    Tokarev A; Skasko M; Fitzpatrick K; Guatelli J
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1197-210. PubMed ID: 19929170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.
    Chen CY; Shingai M; Welbourn S; Martin MA; Borrego P; Taveira N; Strebel K
    J Virol; 2016 Dec; 90(24):11062-11074. PubMed ID: 27681141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1).
    Jones PH; Maric M; Madison MN; Maury W; Roller RJ; Okeoma CM
    Virology; 2013 Mar; 438(1):37-49. PubMed ID: 23411007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.